Catalogue
Chicken anti Clostridium difficile Toxin B
Catalog number: ACdTB| Product Type |
Primary antibodies |
| Units | 0.1 mg |
| Host | Chicken |
| Species Reactivity |
Clostridium |
| Application |
ELISA Western Blotting |
Source
Chickens were immunized with highly purified Toxin B purified from Clostridium difficile. After multiple immunizations in Freund's adjuvant, eggs were collected and the IgY purified. Anti-Clostridium difficile Toxin B was immunoaffinity purified using the immunogen immobilized on a solid support.
Product
Egg-yolk derived affinity purified IgY in phosphate buffered saline‚ pH 7.2 with 0.075% sodium azide
Product Form: Affinity purified
Concentration: See vial for concentration.
Applications
This antibody is suitable for ELISA and Western Blotting procedures. By Direct ELISA, the half-point titre was 1:20,000 using a 2 ug/ml coating of Toxin B. This antibody has also been successfully used in cytotoxicity and neutralization assays (please see embedded image). Optimal working dilutions should be determined for your particular assay conditions.
Storage
Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles.
Shipping Conditions: Ship at ambient temperature
Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.
References
1. Lei X-H and BR Bochner, 2013. Using Phenotype MicroArrays to Determine Culture Conditions That Induce or Repress Toxin Production by Clostridium difficile and Other Microorganisms. PLoS ONE 8(2): e56545. doi:10.1371/journal.pone.0056545
2. Bochner, B and X. Lei. 2015. Compositions and Methods to Inactivate and/or Reduce Production of Microbial Toxins. United States Patent Application 2015 0374786.
3. Tussey, L., Song, L. and S. Umlauf. 2016. Clostridium difficile Compositions and Methods of Use. United States Patent Application 2016016667.
Safety Datasheet(s) for this product:
| NM_Sodium Azide |